Researchers at Leipzig University and Leipzig University Hospital (UKL) have discovered that tumour growth and tissue invasion by cancer cells can be predicted based on the ontogenetic distance between tissues. Simulations of tumour spread patterns and analysis of pathological data yielded ... more
Dr. Katja Schellenberg
Universität Leipzig, Translationszentrum für Regenerative Medizin
completed her studies for a Bachelor of Science in Molecular Biotechnology from TU Dresden before graduating from the international degree programme “Molecular Medicine” at Charité – Universitätsmedizin (Berlin) with an M.Sc. in 2009. Funded by a grant from Charité, she then completed her doctoral work at Berlin’s Freie Universität and Charité – Universitätsmedizinin in the field of molecular chronobiology at the Institute for Medical Immunology. Having acquired additional professional qualification in GLP and a distance learning course in the field of quality management, she has been study director for non-clinical services and safety testing at Leipzig’s Translation Centre for Regenerative Medicine since January 2014. Her particular responsibilities include the planning and execution of testing in accordance with the principles of GLP, as well as project support and coordination work for research-based services.